Plain-English translation of NCT07782164 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
The PELFIRE Study is testing a treatment called irreversible electroporation (IRE) — a procedure that uses precisely controlled electric pulses to destroy cancer cells. This study includes patients whose cancers have returned in the pelvic area (the lower part of your belly) and who cannot have surgery or radiation therapy. Researchers want to learn whether this treatment can help control the cancer and improve outcomes.
When cancer comes back in the pelvis after initial treatment, options are often limited because surgery and radiation may be too risky or not possible. This trial exists to see whether electric pulse therapy could offer patients like you another effective choice when standard treatments aren't suitable.
You likely qualify if…
You likely don't qualify if…
You will receive the electric pulse treatment (irreversible electroporation) as planned by your medical team. The study will collect information about your case from before December 2012 through April 2025, including your imaging scans, treatment details, and how you respond over time. You will be asked to have follow-up imaging and visits so researchers can track how well the treatment works and watch for any side effects.
AI-generated summary from trial data · Aug 26, 2026 · Not medical advice
Netherlands